These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38730013)

  • 1. Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion.
    Mao Y; Wu C; Wang X; Zhang F; Qi X; Li X; Li P; Tang B
    Commun Biol; 2024 May; 7(1):558. PubMed ID: 38730013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model.
    Zhao W; Zhang L; Xu Y; Zhang Z; Ren G; Tang K; Kuang P; Zhao B; Yin Z; Wang X
    Lab Invest; 2014 Feb; 94(2):182-91. PubMed ID: 24296878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma.
    Xia Y; Chen R; Ye SL; Sun R; Chen J; Zhao Y
    Clin Exp Metastasis; 2011 Oct; 28(7):661-74. PubMed ID: 21717117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma.
    Zhao W; Su W; Kuang P; Zhang L; Liu J; Yin Z; Wang X
    Int J Oncol; 2012 Aug; 41(2):457-64. PubMed ID: 22641338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
    Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.
    Tao Z; Ruan H; Sun L; Kuang D; Song Y; Wang Q; Wang T; Hao Y; Chen K
    Cancer Immunol Res; 2019 Jul; 7(7):1135-1147. PubMed ID: 31113805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the role of S100A10 in CD8
    Wang G; Shen X; Jin W; Song C; Dong M; Zhou Z; Wang X
    Cell Death Dis; 2024 Aug; 15(8):573. PubMed ID: 39117605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
    Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J
    Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation.
    Xiao H; Zhang Y; Li Z; Liu B; Cui D; Liu F; Chen D; Liu Y; Ouyang G
    J Pathol; 2021 Oct; 255(2):212-223. PubMed ID: 34228359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
    Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
    Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
    Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
    J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.
    Ruiz de Galarreta M; Bresnahan E; Molina-Sánchez P; Lindblad KE; Maier B; Sia D; Puigvehi M; Miguela V; Casanova-Acebes M; Dhainaut M; Villacorta-Martin C; Singhi AD; Moghe A; von Felden J; Tal Grinspan L; Wang S; Kamphorst AO; Monga SP; Brown BD; Villanueva A; Llovet JM; Merad M; Lujambio A
    Cancer Discov; 2019 Aug; 9(8):1124-1141. PubMed ID: 31186238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
    Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
    Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma.
    Xia YH; Wang ZM; Chen RX; Ye SL; Sun RX; Xue Q; Huang Y
    Oncol Rep; 2013 Sep; 30(3):1175-84. PubMed ID: 23807027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum.
    Xia Y; Chen R; Song Z; Ye S; Sun R; Xue Q; Zhang Z
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):309-21. PubMed ID: 19727817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.